Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation is a research paper published in Journal of Pharmacology and Experimental Therapeutics (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R21 CA168454
NIGMS NIH HHS
Grant: R35 GM131800
NCI NIH HHS
Grant: P30 CA016056
NCI NIH HHS
Grant: U24 CA274159
NCI NIH HHS
Grant: R01 CA198096
NCI NIH HHS
Grant: R21 CA234775
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/MHC-LIN/3901/2014
Horizon21: Early language development in Down Syndrome
National Institutes of Health
Grant: 5R01CA198096-05
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
National Institutes of Health
Grant: 1R21CA168454-01
Pancreas cancer combination therapy based on stromal modulators and nano-carriers
FWCI
0.41
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals